From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19299431.
- Also identified by DOI 10.1093/eurheartj/ehp078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Several physiological and pathophysiological stimuli or drugs modulate endothelial progenitor cell (EPC) mobilization. Moreover, levels of circulating EPCs predict cardiovascular risk and left ventricular remodelling after myocardial infarction. Nevertheless, our understanding in this field is complicated by lack of an unequivocal definition of EPCs, thus limiting their clinical applications. This review summarizes current knowledge and uncertainties on EPC characterization and mobilization in the attempt to define their role in the management of cardiovascular diseases.
Medical subject headings
- Bone Marrow Cells
- Endothelial Cells
- Myocardial Infarction
- Stem Cells